Homburger advised Molecular Partners AG on the offering. Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin...
Molecular Partners AG’s $20 Million Underwritten Offering of American Depositary Shares
Müller Martini’s Acquisition of Hunkeler
Homburger advised Müller Martini on its acquisition of Hunkeler. Müller Martini and Hunkeler, both global market leaders with innovative solutions for post-print paper processing, announced the...
Macquarie Asset Management’s USD$325 Million Investment in Atlas Agro
Homburger advised Atlas Agro in connection with the investment by Macquarie Asset Management of up to USD 325 m. Atlas Agro Holding AG announced the investment...
Siegfried’s 95% Stake Acquisition in DiNAMIQS
Homburger advised Siegfried on its acquisition of a 95% stake in DiNAMIQS. Siegfried, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry...
OC Oerlikon’s Acquisition of Riri
Lenz & Staehelin advised the selling shareholders of RIRI Group in this transaction. Homburger advised OC Oerlikon. Oerlikon, a global innovation provider for surface engineering, polymer...
Solenis’ Acquisition of Kolb’s Paper Process Chemicals Business
Homburger acted as counsel to Solenis in this transaction. Solenis reached an agreement with Kolb Distribution Ltd., a unit of KLK Kolb Group, to acquire Kolb’s...
Addex Therapeutics’ PIPE Transaction With Armistice Capital
Homburger advised Addex in this transaction. Allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has entered into a definitive agreement...
On Holding AG’s Initial Public Offering at NYSE
Lenz & Staehelin advised On Holding AG on the deal. Homburger advised the underwriters. On Holding AG, a Swiss-based athletic shoe and performance sportswear company, successfully...
Molecular Partners’ $63.8 Million Initial Public Offering in The US and Listing on NASDAQ Close
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...